BWP
MRNA icon

BSW Wealth Partners’s Moderna MRNA Stock Holding History

BSW Wealth Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,677
Closed -$204K – 271
2023
Q2 		$204K Sell
1,677
-3
-0.2% -$400 0.04% 254
2023
Q1 		$258K Sell
1,680
-8
-0.5% -$1.32K 0.05% 244
2022
Q4 		$303K Buy
+1,688
New +$276K 0.07% 214
2022
Q3 		– Sell
-1,615
Closed -$231K – 288
2022
Q2 		$231K Buy
1,615
+289
+22% +$41.3K 0.06% 231
2022
Q1 		$228K Buy
1,326
+532
+67% +$89.6K 0.06% 250
2021
Q4 		$202K Sell
794
-55
-6% -$16.1K 0.05% 248
2021
Q3 		$327K Sell
849
-390
-31% -$144K 0.09% 168
2021
Q2 		$291K Buy
+1,239
New +$221K 0.08% 179

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

BSW Wealth Partners's MRNA Position: Q3 2023 in Review

BSW Wealth Partners sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,677 shares — an estimated $204K sold.

BSW Wealth Partners first reported a position in MRNA in Q2 2021 and held it in 8 quarters. The position peaked at $327K in Q3 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • BSW Wealth Partners reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • BSW Wealth Partners sold 1,677 Moderna shares in Q3 2023, an estimated $204K.
  • BSW Wealth Partners first reported a position in Moderna in Q2 2021 and held it in 8 quarters.
  • BSW Wealth Partners's Moderna position peaked at $327K in Q3 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on BSW Wealth Partners's 13F filing for Q3 2023, filed 27 Oct 2023.